Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04153604 · ClinicalTrials.gov registry record
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 841
- Enrollment target
NCT04153604 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 841 participants.
The verdict
NCT04153604 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 841 participants
- Enrollment target
Study Summary
The utilization of doxycycline for SBP prophylaxis is a novel practice at MDMC. Therefore, an assessment of safety and efficacy is needed in order to generalize this practice. The publication of this study can potentially introduce a new alternative to guideline-directed therapies for secondary prevention of SBP. Doxycycline is non-inferior to guideline-directed therapies regarding safety and efficacy in primary and secondary prophylaxis for SBP.
Interventions
- DRUG doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 841 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-08-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04153604
The ClinicalTrials.gov registry entry for NCT04153604 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 841 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which doxycycline is the first listed.
NCT04153604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04153604 about?
NCT04153604 is a clinical study titled "Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis". The utilization of doxycycline for SBP prophylaxis is a novel practice at MDMC. Therefore, an assessment of safety and efficacy is needed in order to generalize this practice. The publication of this study can potentially introduce a new alternative to guideline-directed therapies for secondary prev...
What is the current status of trial NCT04153604?
This trial is currently completed. The enrollment target is 841 participants. The study started on 2019-11-04. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT04153604?
The interventions under investigation include: doxycycline (DRUG).
Who is sponsoring clinical trial NCT04153604?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.